Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-24-001576

CEO, Pres., CFO, Treas & Secty bought 5,200 shares at $0.97 ($5,044)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Francis Knuettel II CEO, Pres., CFO, Treas & Secty 2024-09-12 Purchase +1,700 $0.97 $1,649 544,210 I
Francis Knuettel II CEO, Pres., CFO, Treas & Secty 2024-09-13 Purchase +3,500 $0.97 $3,395 547,710 I
Open-market purchases · 5,200 sh · avg $0.97 · $5,044
Loading xslF345X05/ownership.xml…